Ledger.Open graph →
SEC Form D · filed January 13, 2023

Perceive Biotherapeutics, Inc

Offering
$78.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kirsten A. Macfarlane · South San Francisco, CAExec · Director · PromoterCameron A. Wheeler · South San Francisco, CADirectorWatson A. Debi · South San Francisco, CADirectorAnne A. Rubin · South San Francisco, CAExec · DirectorRandall A. Olson · South San Francisco, CADirectorRobert A. Jackson · South San Francisco, CADirectorWatson A. Debi · South San Francisco, CADirectorAnne A. Rubin · South San Francisco, CAExec · DirectorKirsten A. Macfarlane · South San Francisco, CAExec · Director · PromoterCameron A. Wheeler · South San Francisco, CADirectorRandall A. Olson · South San Francisco, CADirectorRobert A. Jackson · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗